NCT01403519 Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized Status UNKNOWN Phase N/A
NCT01399125 A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01397578 A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01397539 Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01388478 Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01385033 [18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002) Status TERMINATED Phase PHASE1
NCT01380288 Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine Status COMPLETED Phase NA
NCT01378195 iCare Stress Management e-Training for Dementia Family Caregivers Status COMPLETED Phase PHASE2
NCT01374438 3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01370954 NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support) Status COMPLETED Phase N/A
NCT01369225 Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01354691 Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01350362 Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients Status COMPLETED Phase PHASE2
NCT01348737 Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01343966 A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) Status COMPLETED Phase PHASE2
NCT01329536 The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease Status COMPLETED Phase N/A